Stryker nominates Quest Diagnostics CEO Jim Davis to board
- Stryker's board on Nov. 9, 2026, nominated Jim Davis for election as a director, effective Jan. 1, 2027.
- Davis is chairman, CEO and president of Quest Diagnostics, with leadership experience in healthcare, medical technology and global operations.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stryker Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-453635), on November 09, 2026, and is solely responsible for the information contained therein.